Klauser, AM;
Wiebenga, OT;
Eijlers, AJ;
Schoonheim, MM;
Uitdehaag, BM;
Barkhof, F;
Pouwels, PJ;
(2018)
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.
Multiple Sclerosis Journal
, 24
(4)
pp. 491-500.
10.1177/1352458517702534.
Preview |
Text
Barkhof_Klauser_MRSI_in_MS.pdf - Accepted Version Download (269kB) | Preview |
Abstract
BACKGROUND: Multiple sclerosis is characterized by white matter lesions, which are visualized with conventional T2-weighted magnetic resonance imaging (MRI). Little is known about local metabolic processes preceding the appearance and during the pathological development of new lesions. OBJECTIVE: To identify metabolite changes preceding white matter (WM) lesions and pathological severity of lesions over time. METHODS: A total of 59 relapsing-remitting multiple sclerosis (MS) patients were scanned four times, with 6-month intervals. Imaging included short-TE magnetic resonance spectroscopic imaging (MRSI) and diffusion tensor imaging (DTI). RESULTS: A total of 16 new lesions appeared within the MRSI slab in 12 patients. Glutamate increased (+1.0 mM (+19%), p = 0.039) 12 and 6 months before new lesions appeared. In these areas, the increase in creatine and choline 6 months before until lesion appearance was negatively correlated with radial diffusivity (ρ = -0.73, p = 0.002 and ρ = -0.72, p = 0.002). Increase in creatine also correlated with the increase of axial diffusivity in the same period (ρ = -0.53, p = 0.034). When splitting the lesions into "mild" and "severe" based on radial diffusivity, only mild lesions showed an increase in creatine and choline during lesion formation ( p = 0.039 and p = 0.008, respectively). CONCLUSION: Increased glutamate heralded the appearance of new T2-visible WM lesions. In pathologically "mild" lesions, an increase in creatine and choline was found during lesion formation.
Archive Staff Only
 |
View Item |
